Effect of donkey milk on the new corona virus infection

Evaluation of the effect of dairy product donkey milk on the course of signs of patients with suspected corona disease (COVID-19)

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20161108030776N3

Enrollment

110

Registered

2020-08-26

Start date

2020-09-05

Completion date

Unknown

Last updated

2020-09-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19. COVID-19

Interventions

Intervention 1: Intervention group: In addition to drug treatment according to the protocol of the Ministry of Health, patients in this group receive donkey milk at a rate of 300 cc daily with 5 grams

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Patients with COVID-19 Mild to moderate disease Candidates for outpatient treatment based on the protocol of the Ministry of Health Patients 18-65 years old

Exclusion criteria

Exclusion criteria: Patients with allergies and asthma Patients with hypertension Patients with diabetes Pregnancy / lactation Patients with heart failure Patients with chronic renal failure Patients undergoing chemotherapy Patients receiving corticosteroids Patients with immunodeficiency

Design outcomes

Primary

Measure	Time frame
Body temperature. Timepoint: Days 0-1-2-3-4-7-14 after the start of the intervention. Method of measurement: Mercury thermometer.;Cough (severity-frequency). Timepoint: Days 0-1-2-3-4-7-14 after the start of the intervention. Method of measurement: Fiston Scale.;Weakness and lethargy. Timepoint: Days 0-1-2-3-4-7-14 after the start of the intervention. Method of measurement: Visual analog scale (VAS).;Body pain. Timepoint: Days 0-1-2-3-4-7-14 after the start of the intervention. Method of measurement: Visual analog scale (VAS).;Breathing speed. Timepoint: Days 0-1-2-3-4-7-14 after the start of the intervention. Method of measurement: Count the number of breaths per minute.;Diarrhea (watery stools). Timepoint: Days 0-1-2-3-4-7-14 after the start of the intervention. Method of measurement: Question from the patient.	—

Measure

Time frame

Body temperature. Timepoint: Days 0-1-2-3-4-7-14 after the start of the intervention. Method of measurement: Mercury thermometer.;Cough (severity-frequency). Timepoint: Days 0-1-2-3-4-7-14 after the start of the intervention. Method of measurement: Fiston Scale.;Weakness and lethargy. Timepoint: Days 0-1-2-3-4-7-14 after the start of the intervention. Method of measurement: Visual analog scale (VAS).;Body pain. Timepoint: Days 0-1-2-3-4-7-14 after the start of the intervention. Method of measurement: Visual analog scale (VAS).;Breathing speed. Timepoint: Days 0-1-2-3-4-7-14 after the start of the intervention. Method of measurement: Count the number of breaths per minute.;Diarrhea (watery stools). Timepoint: Days 0-1-2-3-4-7-14 after the start of the intervention. Method of measurement: Question from the patient.

—

Secondary

Measure	Time frame
Being admitted to the hospital. Timepoint: Days 0-1-2-3-4-7-14 after the start of the intervention. Method of measurement: The ratio of the number of cases leading to hospitalization to the total number of patients in each group.;Death rate. Timepoint: Days 0-1-2-3-4-7-14 after the start of the intervention. Method of measurement: Ratio of number of deaths to total patients in each group.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHaleh Tajadini

Kerman University of Medical Sciences

dr_haleh@yahoo.com+98 34 3211 0860

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026